Full Content is available to subscribers

Subscribe/Learn More  >

Magnesium Oxide Based PLGA/Chitosan Microparticles for Controlled Release Study

[+] Author Affiliations
Shekh Rahman, Narayan Bhattarai

North Carolina A&T State University, Greensboro, NC

Paper No. IMECE2015-52143, pp. V014T11A034; 4 pages
  • ASME 2015 International Mechanical Engineering Congress and Exposition
  • Volume 14: Emerging Technologies; Safety Engineering and Risk Analysis; Materials: Genetics to Structures
  • Houston, Texas, USA, November 13–19, 2015
  • Conference Sponsors: ASME
  • ISBN: 978-0-7918-5757-1
  • Copyright © 2015 by ASME


The performance of a therapeutic drug can be optimized by controlling the rate and extent of its release in the body. Polymeric microparticles are ideal vehicles for many controlled release drug delivery applications. Poly(lactic-co-glycolic acid) (PLGA) is a biodegradable, biocompatible and FDA approved synthetic polymer. When PLGA based controlled release drug delivery devices are fabricated, the surface of PLGA is typically modified by other hydrophilic polymers. But some hydrophilic polymers, such as poly(ethylene glycol) (PEG) can negatively influence the therapeutic outcomes. The goal of the present study was to fabricate and investigate the PLGA/chitosan microparticles for controlled release of therapeutic drugs. Chitosan is a naturally occurring biodegradable polysaccharide. We hypothesized that chitosan could be used as a surface coating of PLGA to improve controlled release of therapeutic drugs. The double emulsion solvent evaporation technique was modified and utilized to fabricate the PLGA/chitosan microparticles. The microparticles were tested with respect to several physicochemical properties, such as morphology, size distribution, chemical structure, quantification of chitosan content and in vitro release study of model drug. Magnesium is an essential electrolyte in the human body. Magnesium oxide (MgO) is used for treatment of magnesium deficiency. MgO was encapsulated in the PLGA/chitosan microparticles as a model drug.

Copyright © 2015 by ASME



Interactive Graphics


Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In